APA (7th ed.) Citation

Mackey, J., Pienkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., . . . in, T. R. I. O. (2016). Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial. Oxford University Press.

Chicago Style (17th ed.) Citation

Mackey, J., et al. Long-term Outcomes After Adjuvant Treatment of Sequential Versus Combination Docetaxel with Doxorubicin and Cyclophosphamide in Node-positive Breast Cancer: BCIRG-005 Randomized Trial. Oxford University Press, 2016.

MLA (9th ed.) Citation

Mackey, J., et al. Long-term Outcomes After Adjuvant Treatment of Sequential Versus Combination Docetaxel with Doxorubicin and Cyclophosphamide in Node-positive Breast Cancer: BCIRG-005 Randomized Trial. Oxford University Press, 2016.